MAX COVID EUA FDA Response
Research payments
$951,098
Through program year 2021, $951,098 in research payments was reported against MAX COVID EUA FDA Response, across 13 payments, paid by Becton, Dickinson and Company.
- Paid by
- Becton, Dickinson and Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $897,094 | 7 |
| 2020 | Research | $54,004 | 6 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
4 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.